Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Hepatic Injury

NCT01325584 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Alternative product is now approved and available for use.

Conditions

Cancer
Hepatic Injury

Interventions

DRUG: Omegaven

Sponsor

Midwestern Regional Medical Center